J0391 HCPCS code: Injection, artesunate, 1 mg
J0391 is the HCPCS Level II code for injection, artesunate, 1 mg. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 770 per day on outpatient hospital claims.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2024-01-01 |
| Last action effective | 2024-01-01 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 770 | CMS Policy |
| practitioner claims | 770 | CMS Policy |
What changed for J0391
- 2024-01-01: J0391 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J0391?
J0391 is the HCPCS Level II code for injection, artesunate, 1 mg. Short descriptor: "Inj, artesunate, 1mg".
Does Medicare cover J0391?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of J0391 can be billed per day?
770 on outpatient hospital claims; 770 on practitioner claims (NCCI medically unlikely edits).
Related J03 codes
- J0300 — Injection, amobarbital, up to 125 mg
- J0330 — Injection, succinylcholine chloride, up to 20 mg
- J0348 — Injection, anidulafungin, 1 mg
- J0349 — Injection, rezafungin, 1 mg
- J0350 — Injection, anistreplase, per 30 units
- J0360 — Injection, hydralazine hcl, up to 20 mg
- J0364 — Injection, apomorphine hydrochloride, 1 mg
- J0365 — Injection, aprotonin, 10,000 kiu
- J0380 — Injection, metaraminol bitartrate, per 10 mg
- J0390 — Injection, chloroquine hydrochloride, up to 250 mg
- J0395 — Injection, arbutamine hcl, 1 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J0391
- Watch J0391 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J0391
Sources: CMS HCPCS Level II release October 2026; CMS DMEPOS fee schedule; CMS NCCI MUE tables; CMS Medicare utilization (physician and DME supplier files); CMS Medicare Coverage Database articles. Fees are Medicare allowables, not commercial rates. Not billing or legal advice.